Background:
Incomplete cervical dilation is one most burning and upcoming bovine obstetrical problems and requires a holistic approach to treat the cervix for successful dilation and prevent the animal from undergoing cesarean section. The hospital incidence of ICD in cattle and buffaloes is 34.9% and many a time failure of cervical dilation leads to C-section which is quite costly and also animal future fertility become questionable. Apart from this, there was no device to deliver the drug into the seminal vesicle in case of seminal vesiculitis of precious pedigree bulls. In northern states due to a strict ban on cow slaughter, a lot of female cattle roaming on the road, and there is a need for chemosterilization to control their population against a non-surgical method which is costly and requires a lot of post-operative care to check their population.:
Technology Details:
It is well-established fact that some of the drugs like a few pharmacological agents (PGE2 & Hyaluronidase) have a significant role in cervical dilation if administered intra-cervical. In non-surgical chemosterilization of unproductive free-roaming female cattle which requires chemosterilant delivery at the site of both the ovaries and also in many cases of seminal vesiculitis, the precious pedigreed bull requires drug delivery at the site of seminal vesicles. Keeping all these problems in mind, an internal drug delivery device in the name of “Internal Genital Injection Device” has been developed wherein a syringe of the capacity of 3 to 10 ml could be loaded and under epidural anesthesia (if required) drug/chemical may be delivered at the site of the cervix in case of dystocia due to incomplete cervical dilation, at the site of seminal vesicle in case of seminal vesiculitis in bull and at the site of ovaries to make cattle sterile with the mean of chemosterilisation to control stray cattle population.